Both companies will promote this initiative by leveraging Fujitsu’s expertise in reliable medical and pharmaceutical data management and IT technologies, as well as Salesforce Japan’s track record and expertise as an industry leader. customer relationship management (CRM).
As part of the first stage of their collaboration, Fujitsu and Salesforce Japan will work together to develop digital solutions for insurance companies in Japan. The two companies will cooperate with insurance companies and medical institutions to support the development of insurance products that optimize individuals’ assessment of disease risks based on data such as the possibility of diseases predicted by AI from medical and health data. Both parties are targeting commercialization of the new solutions in Japan in fiscal year 2023.
With the new solutions, Fujitsu and Salesforce Japan will support the establishment of new product models for insurance companies and promote the widespread use of personalized insurance products. The two companies thus aim to contribute to the resolution of societal and economic problems, in particular health problems linked to various diseases associated with the extension of the life expectancy of individuals, the increase in treatment costs due to healthcare advanced medical conditions and the cost of living during the retirement period.
Yoshinami Takahashi, Corporate Executive Officer, EVP, Fujitsu Limited, comments: “Through this collaboration, we ultimately aim to deliver new solutions within our Healthy Living portfolio of offerings, contributing not only to the transformation of health care in Japan, but across the whole world.”
Hidenori Tamura, General Manager of Salesforce Japan, comments, “There is a gap between the healthcare services consumers demand and the services actually provided. Salesforce research shows that more than 80% of consumers are interested in personalized healthcare services, while about 30% of companies actually provide them To meet consumer needs, it is essential that the various industry players connect and collaborate with patients to create solutions”.